ION BEAM APPLICATIONS (IBAB.BR) Stock Fundamental Analysis
EBR:IBAB - Euronext Brussels - BE0003766806 - Common Stock - Currency: EUR
IBAB gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. IBAB has a medium profitability rating, but doesn't score so well on its financial health evaluation. IBAB is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IBAB was profitable.
In the past year IBAB has reported a negative cash flow from operations.
Of the past 5 years IBAB 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: IBAB reported negative operating cash flow in multiple years.
1.2 Ratios
IBAB's Return On Assets of 1.50% is in line compared to the rest of the industry. IBAB outperforms 45.00% of its industry peers.
IBAB has a Return On Equity of 8.34%. This is in the better half of the industry: IBAB outperforms 65.00% of its industry peers.
IBAB's Return On Invested Capital of 11.77% is amongst the best of the industry. IBAB outperforms 90.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IBAB is below the industry average of 8.41%.
The 3 year average ROIC (6.33%) for IBAB is below the current ROIC(11.77%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 8.34% | ||
| ROIC | 11.77% |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.33%
ROIC(5y)6.79%
1.3 Margins
IBAB has a Profit Margin of 1.86%. This is comparable to the rest of the industry: IBAB outperforms 41.67% of its industry peers.
In the last couple of years the Profit Margin of IBAB has declined.
IBAB has a Operating Margin of 5.60%. This is comparable to the rest of the industry: IBAB outperforms 41.67% of its industry peers.
IBAB's Operating Margin has improved in the last couple of years.
The Gross Margin of IBAB (33.32%) is worse than 78.33% of its industry peers.
IBAB's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.6% | ||
| PM (TTM) | 1.86% | ||
| GM | 33.32% |
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so IBAB is still creating some value.
Compared to 1 year ago, IBAB has more shares outstanding
The number of shares outstanding for IBAB has been reduced compared to 5 years ago.
IBAB has a worse debt/assets ratio than last year.
2.2 Solvency
IBAB has an Altman-Z score of 1.49. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
IBAB has a worse Altman-Z score (1.49) than 61.67% of its industry peers.
IBAB has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of IBAB (0.23) is better than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.49 |
ROIC/WACC1.64
WACC7.16%
2.3 Liquidity
IBAB has a Current Ratio of 0.95. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB's Current ratio of 0.95 is on the low side compared to the rest of the industry. IBAB is outperformed by 78.33% of its industry peers.
IBAB has a Quick Ratio of 0.95. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
IBAB has a Quick ratio of 0.63. This is amonst the worse of the industry: IBAB underperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.63 |
3. Growth
3.1 Past
IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 195.83%, which is quite impressive.
The Earnings Per Share has been growing slightly by 3.99% on average over the past years.
Looking at the last year, IBAB shows a small growth in Revenue. The Revenue has grown by 6.75% in the last year.
The Revenue has been growing by 12.01% on average over the past years. This is quite good.
EPS 1Y (TTM)195.83%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%5.14%
Revenue 1Y (TTM)6.75%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%-1.87%
3.2 Future
Based on estimates for the next years, IBAB will show a very strong growth in Earnings Per Share. The EPS will grow by 79.05% on average per year.
The Revenue is expected to grow by 2.63% on average over the next years.
EPS Next Y267%
EPS Next 2Y133.02%
EPS Next 3Y79.05%
EPS Next 5YN/A
Revenue Next Year16.54%
Revenue Next 2Y11.73%
Revenue Next 3Y8.91%
Revenue Next 5Y2.63%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 40.33 indicates a quite expensive valuation of IBAB.
Compared to the rest of the industry, the Price/Earnings ratio of IBAB is on the same level as its industry peers.
IBAB is valuated expensively when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
IBAB is valuated correctly with a Price/Forward Earnings ratio of 12.93.
80.00% of the companies in the same industry are more expensive than IBAB, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, IBAB is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.33 | ||
| Fwd PE | 12.93 |
4.2 Price Multiples
IBAB's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBAB is cheaper than 86.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.54 |
4.3 Compensation for Growth
IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IBAB's earnings are expected to grow with 79.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.15
PEG (5Y)10.12
EPS Next 2Y133.02%
EPS Next 3Y79.05%
5. Dividend
5.1 Amount
IBAB has a Yearly Dividend Yield of 1.37%.
IBAB's Dividend Yield is a higher than the industry average which is at 2.27.
Compared to an average S&P500 Dividend Yield of 2.38, IBAB's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.37% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
IBAB pays out 52.84% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP52.84%
EPS Next 2Y133.02%
EPS Next 3Y79.05%
EBR:IBAB (5/30/2025, 7:00:00 PM)
12.1
-0.12 (-0.98%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners29.32%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap366.39M
Analysts80
Price Target16.52 (36.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.37% |
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP52.84%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-5.12%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.31%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.33 | ||
| Fwd PE | 12.93 | ||
| P/S | 0.74 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.3 | ||
| P/tB | 4.3 | ||
| EV/EBITDA | 8.54 |
EPS(TTM)0.3
EY2.48%
EPS(NY)0.94
Fwd EY7.73%
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS16.45
BVpS3.66
TBVpS2.82
PEG (NY)0.15
PEG (5Y)10.12
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.5% | ||
| ROE | 8.34% | ||
| ROCE | 18.95% | ||
| ROIC | 11.77% | ||
| ROICexc | 23.1% | ||
| ROICexgc | 35.13% | ||
| OM | 5.6% | ||
| PM (TTM) | 1.86% | ||
| GM | 33.32% | ||
| FCFM | N/A |
ROA(3y)0.32%
ROA(5y)1.58%
ROE(3y)1.66%
ROE(5y)6.12%
ROIC(3y)6.33%
ROIC(5y)6.79%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.19%
ROCE(5y)10.93%
ROICexcg growth 3YN/A
ROICexcg growth 5Y53.77%
ROICexc growth 3Y-88.07%
ROICexc growth 5Y51.35%
OM growth 3Y8.91%
OM growth 5Y47.94%
PM growth 3Y14.44%
PM growth 5Y-7.16%
GM growth 3Y-1.07%
GM growth 5Y0.22%
F-Score5
Asset Turnover0.81
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.65 | ||
| Cap/Depr | 63.41% | ||
| Cap/Sales | 1.49% | ||
| Interest Coverage | 20.73 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.63 | ||
| Altman-Z | 1.49 |
F-Score5
WACC7.16%
ROIC/WACC1.64
Cap/Depr(3y)79.57%
Cap/Depr(5y)64.6%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.81%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)195.83%
EPS 3Y33.53%
EPS 5Y3.99%
EPS Q2Q%5.14%
EPS Next Y267%
EPS Next 2Y133.02%
EPS Next 3Y79.05%
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3Y16.76%
Revenue growth 5Y12.01%
Sales Q2Q%-1.87%
Revenue Next Year16.54%
Revenue Next 2Y11.73%
Revenue Next 3Y8.91%
Revenue Next 5Y2.63%
EBIT growth 1Y269.56%
EBIT growth 3Y27.16%
EBIT growth 5Y65.71%
EBIT Next Year224.83%
EBIT Next 3Y67.74%
EBIT Next 5YN/A
FCF growth 1Y43.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y46.44%
OCF growth 3YN/A
OCF growth 5YN/A